GLP-1 Medications
Plain-English guides to Ozempic, Wegovy, Mounjaro, Zepbound, Saxenda, and the science behind GLP-1 receptor agonists.
- Mounjaro Japan: Price, Rules, and Why Koreans Fly There6 minMounjaro Japan price explained: why tirzepatide costs about a quarter in Japan, Korea's new Nov 12 import rule, Zepbound rules in Japan, and what it means for you.
- What Is NovoCare? The New Free App, Points and Prices5 minWhat is NovoCare? Novo Nordisk relaunched it on Nov 17, 2026 as a free membership with an app, coaches, partner perks, coming points, and Wegovy self-pay prices.
- Zepbound KwikPen How to Use: Priming, Dosing, Needles7 minZepbound KwikPen how to use, step by step from the FDA Instructions for Use: needles, the 2-click prime, dialing one dose, the 5-second hold and storage.
- Efsubaglutide Alfa: Innogen GLP-1 Results and US Status6 minEfsubaglutide alfa (supaglutide) explained: what Innogen's GLP-1 is, its China approval, 10.6% weight loss in 18 weeks, the Arcera deal and US status.
- Foundayo Canada: Health Canada Approval, Price, Launch Date5 minFoundayo Canada: Health Canada approved orforglipron, the daily GLP-1 pill from Lilly, on Nov 13, 2026. Who qualifies, the January launch, price and coverage.
- Maryland Ozempic Price Cap: The $274 Limit, Explained5 minMaryland Ozempic price cap: the state set a $274 per 30-day limit for government health plans. Who it covers, when it starts, and what it means at the pharmacy.
- Foundayo Australia: TGA Approval, Price and Availability6 minFoundayo Australia: the TGA has registered orforglipron, the GLP-1 pill from Lilly. Who can get it, the $250 to $370 price, PBS status and when it arrives.
- FAA Ozempic Rules: Can Pilots Take GLP-1 Drugs? (2026)6 minFAA Ozempic rules for pilots: which GLP-1 drugs the FAA accepts for weight loss, the 1-week and 48-hour no-fly windows, A1C limits and what your AME needs.
- Phentermine vs GLP-1: Weight Loss, Safety, Cost (2026)7 minPhentermine vs GLP-1: how the cheap old pill compares with Wegovy and Zepbound on weight loss, side effects and cost, plus the new 2-year LEAP trial results.
- Mounjaro Canada: New Heart Approval, Price, Coverage (2026)7 minMounjaro Canada: Health Canada approved tirzepatide to lower heart risk in type 2 diabetes on Nov 18, 2026. Indications, price, coverage and savings card.
- CagriSema Dose: Lower Doses Lost About 21% in REDEFINE 97 minCagriSema dose news: 1.0 mg and 1.7 mg lost about 21% in REDEFINE 9. See every dose tested, why there is no official dosage chart yet, and FDA status.
- Switching From Semaglutide to Tirzepatide: New 2-Year Data7 minSwitching from semaglutide to tirzepatide beat staying put in a 20,486-patient Cleveland Clinic study. See the results, the label rules and what to expect.
- Zepbound for Teens: Is It Approved? New Trial Results6 minZepbound for teens is not FDA approved yet. See the new SURMOUNT-ADOLESCENTS results (BMI down 21.4% at 72 weeks), safety unknowns and approved options.
- Semaglutide With B12: Benefits, Side Effects, New Study7 minSemaglutide with B12 is a compounded shot, not an FDA-approved drug. See what a new JAMA study, the FDA and the research say about benefits and risks.
- Mazdutide: What It Is, Results, Side Effects, FDA Status7 minMazdutide is a weekly GLP-1 and glucagon shot approved in China, not by the FDA. See trial results, side effects, new coverage news and how it compares.
- CVS Caremark GLP-1 Coverage 2026: Wegovy, Zepbound, Foundayo7 minCVS Caremark GLP-1 coverage in 2026: Wegovy and Zepbound are both preferred, Foundayo is open to plans, and CVS says the drugs pay off under $350 a month.
- Wegovy Pill Results: 6.2% in 3 Months, Timeline, vs Shot7 minWegovy pill results: new real-world data show 6.2% weight loss in 3 months. See the timeline by month, the 64-week trial results and pill vs injection.
- Missed GLP-1 Dose: Label Rules as CDC Finds 28% Skip6 minMissed GLP-1 dose? See the label rule for Ozempic, Wegovy, Zepbound, Mounjaro and the pills, plus the new CDC report: 28% of users skip doses.
- Zepbound Dosage Chart: Doses in Order, mL, Units, Schedule9 minZepbound dosage chart from the FDA label: 2.5 mg start, 5 mg at week 5, 15 mg max, mL per pen, vial and KwikPen, why units are risky, results by dose.
- VK2735: Viking Weight Loss Shot and Pill, Phase 3 Results8 minVK2735 is the Viking Therapeutics GLP-1/GIP weight loss drug, tested as a weekly shot and a daily pill. Trial results, side effects, phase 3 and FDA status.
- Orforglipron China Approval: First GLP-1 Weight Loss Pill7 minOrforglipron China approval: on November 12, 2026, China cleared Lilly's daily GLP-1 pill (Foundayo in the US) for weight loss. Who qualifies, price, launch.
- DJ Khaled Wegovy: 75 Pounds, His Routine and the Fine Print6 minDJ Khaled Wegovy news: he says he lost 75 pounds in a year on Wegovy with walking and golf. See what he takes, his routine and what typical results look like.
- Berobenatide: Pfizer Weight Loss Drug, Monthly Shot Results7 minBerobenatide is the Pfizer weight loss drug given as a once-monthly GLP-1 shot. See trial results, side effects, Phase 3 trials, the Blackstone deal and timing.
- Foundayo Sleep Apnea Results: What the Pill Did in Phase 37 minFoundayo sleep apnea results: the orforglipron pill cut breathing pauses by up to 43.8% in the ATTAIN-OSA trials. FDA status, CPAP, side effects, Zepbound.
- Wegovy Pill Mexico: Pharmacy Launch, Price and US Rules7 minWegovy pill Mexico: Novo Nordisk began shipping daily Wegovy tablets to Mexican pharmacies on Nov 11, 2026. Price, prescription and US border rules.
- ASC30: Ascletis GLP-1 Pill Results, Phase 3 and FDA Status7 minASC30 is the Ascletis once-daily GLP-1 pill for weight loss. See the phase 2 results, the AURORA phase 3 trials, the monthly shot and the new amylin combo.
- Generic Ozempic South Africa: Aspen Semaglutide Approved6 minGeneric Ozempic South Africa update: Aspen semaglutide won approval on Nov 11, 2026. Who can get it, launch timing, price clues, Brazil and Canada status.
- Zepbound Psoriatic Arthritis: 1-Year Taltz Combo Results6 minZepbound psoriatic arthritis update: at one year, 43.7% on Taltz plus Zepbound reached ACR50 vs 15.7% on Taltz alone. Approval status, safety, savings.
- Hims FTC Lawsuit: 5 More States Join, What Patients Should Do6 minHims FTC lawsuit update: five more states joined on November 10, 2026. See the privacy and billing claims, what is not decided yet, and steps for GLP-1 patients.
- GLP-1 for Kids Under 12: What Is Approved and What Is Next6 minGLP-1 for kids under 12: no US approval for obesity yet, what the SCALE Kids and STEP Young trials found, the EU Saxenda decision and the rise in off-label use.
- Foundayo Blood Pressure: Does Orforglipron Lower BP?6 minFoundayo blood pressure facts: new AHA 2026 data show orforglipron lowered systolic BP by about 6 points. Label numbers on low BP, heart rate and BP meds.
- MariTide (Maridebart Cafraglutide): Results, Dosing, Approval6 minMariTide (maridebart cafraglutide) is Amgen's once-monthly obesity shot. Phase 2 weight loss, side effects, Phase 3 status and how it compares to Zepbound.
- Ozempic Babies: Meaning, Risks and the Latest News (2026)5 minOzempic babies meaning: why some women get pregnant on GLP-1s, what the birth defect data show, the new ACOG advice and what the labels say. Plain English.
- Survodutide: Results, Side Effects, Heart Safety, FDA Status7 minSurvodutide is Boehringer Ingelheim's weekly glucagon/GLP-1 shot. Phase 3 weight loss, new heart safety data, side effects, FDA status and vs tirzepatide.
- Wegovy Pill NZ: Medsafe Application, Cost and Release Date6 minWegovy pill NZ: Medsafe is reviewing its first application for daily Wegovy tablets. What it means, likely timing, cost, Pharmac funding and the injection.
- Switching From Injection to Pill: Wegovy, Ozempic, Foundayo7 minSwitching from injection to pill on a GLP-1? What the Wegovy, Ozempic and Rybelsus labels say about timing and doses, plus what the Foundayo switch trial found.
- Zepbound KwikPen Coupon: $299 Self-Pay Card and Copay Terms7 minZepbound KwikPen coupon explained: Lilly's self-pay card from $299, the 45-day refill rule, who can use it, the $50 Medicare Bridge, and needle costs.
- Wegovy Heart Failure: Is It FDA Approved? Trials and Coverage7 minWegovy heart failure: is Wegovy FDA approved for heart failure? What the label says, what STEP-HFpEF showed, how Zepbound compares and Medicare coverage.
- Wegovy MASH: FDA Approval, Criteria, Dosing and New Data8 minWegovy for MASH is FDA approved for F2 to F3 liver scarring without cirrhosis. See the criteria, label dosing, ESSENCE results and the new Nov 2026 data.
- Mounjaro Coupon Card 2026: $25 and $499 Savings Card Terms6 minMounjaro coupon card 2026: who pays $25, who pays $499, the $150 and $647 monthly caps, Medicare rules, GoodRx limits and how to use the Lilly savings card.
- Does Medicare Cover Wegovy? Weight Loss, Heart, MASH (2026)6 minDoes Medicare cover Wegovy? For weight loss only through the $50 GLP-1 Bridge. For heart disease or MASH, a Part D plan can, but a Nov 2026 study found few do.
- Retatrutide vs Semaglutide vs Tirzepatide: 2026 Comparison7 minRetatrutide vs semaglutide vs tirzepatide: weight loss, head-to-head trials, side effects, doses, muscle loss, price and FDA status, compared in plain English.
- Mounjaro Drug Class: What Type of Drug Is Tirzepatide?6 minMounjaro drug class explained: a dual GIP and GLP-1 receptor agonist, not insulin. See its FDA indications, how it differs from Ozempic, and ICD-10 codes.
- CagriSema vs Tirzepatide: REIMAGINE 5 and REDEFINE 4 Explained7 minCagriSema vs tirzepatide: REIMAGINE 5 showed 12.4% vs 9.1% weight loss at low doses, but tirzepatide 15 mg won REDEFINE 4. What both trials mean for you.
- Mounjaro PBS: Listing Ceased, What Australians Pay Now6 minMounjaro PBS news: the listing process has ceased, so there is no $25 script. See why Lilly walked away, private prices by dose and your PBS options.
- Hims Zepbound Cost: Lilly Deal, Foundayo Prices, How It Works7 minHims Zepbound cost starts at $299 a month and Foundayo at $149 under the new Lilly and Hims & Hers deal. See prices by dose, fine print and what is unconfirmed.
- Dr. Reddy's Semaglutide: Brazil Approval, Canada, Price6 minDr. Reddy's semaglutide, a generic Ozempic copy, won Brazil approval on Nov 5, 2026. Where it is sold, strengths, price, recalls and the US status.
- Retatrutide Knee Osteoarthritis Results: Pain Down Up to 76%5 minRetatrutide knee osteoarthritis results from TRIUMPH-4 and TRIUMPH-1: knee pain down up to 75.8%, 1 in 8 pain-free, side effects, and what ACR 2026 adds.
- Wegovy Sales 2026: What Novo's Q3 Numbers Mean for You5 minWegovy sales 2026: Novo Nordisk's Q3 report shows the Wegovy pill at 80% of new US prescriptions. What it means for price, supply and your treatment.
- Wegovy Pill vs Foundayo: Weight Loss, Side Effects, Cost8 minWegovy pill vs Foundayo, compared from the FDA labels: 13.6% vs 11.1% average weight loss, food rules, side effects, doses and November 2026 prices.
- Bofanglutide (GZR18): The Once-Monthly GLP-1 Shot Explained6 minBofanglutide (GZR18) is Gan & Lee's GLP-1 shot dosed every 2 weeks, then monthly. GRADUAL-1 and GRADUAL-3 results, side effects, vs semaglutide and tirzepatide.
- Wegovy Pill Australia: TGA Approval, Cost and Release Date6 minWegovy pill Australia: the TGA approved daily semaglutide tablets (1.5 to 25 mg) in Nov 2026. Release date, likely cost, PBS status and how it compares.
- GLP-1 Drugs List 2026: Every FDA-Approved Brand and Price7 minGLP-1 drugs list for November 2026: every FDA-approved brand, pill or shot, what each treats, trial weight loss, self-pay prices, and what is still pending.
- Wegovy HD vs Zepbound: Weight Loss, Side Effects, Cost8 minWegovy HD vs Zepbound: 7.2 mg semaglutide vs tirzepatide 15 mg. Trial weight loss, Lilly's indirect comparison, side effects, self-pay prices and who fits.
- GLP-1 Off Label Use: What It Means, Uses, Risks (2026)7 minGLP-1 off label use explained: what it means, the 1.1 million Americans in a new study, common off label uses and their evidence, cost, and risks to weigh.
- LillyDirect Phone Number: Customer Service, Pharmacy, Providers5 minLillyDirect phone number for patients is 1-844-559-3471. Here are the official Lilly lines for providers, pharmacies, Zepbound savings and side effects.
- GLP-1 for Seniors: Is It Safe Over 65? Medicare and Risks7 minGLP-1 for seniors: what the Wegovy and Zepbound labels say about adults over 65 and 75, the real risks, Medicare coverage in 2026, and how to protect muscle.
- Ozempic and Kidney Disease: FDA Use, FLOW Results, Risks7 minOzempic and kidney disease: why the FDA approved it for CKD in type 2 diabetes, what the FLOW trial found, kidney injury and stone risks, and protein tips.
- Trulicity vs Ozempic: A1C, Weight Loss, Cost, Side Effects6 minTrulicity vs Ozempic compared: SUSTAIN 7 head-to-head A1C and weight loss results, doses, side effects, heart and kidney uses, savings cards and cost.
- GLP-1 for Teens: Which Drugs Are FDA Approved, and at What Age7 minGLP-1 for teens: which drugs the FDA approves under 18 (Wegovy, Saxenda, Mounjaro, Trulicity, Victoza), the youngest ages, teen trial results and side effects.
- Semaglutide vs Tirzepatide: Weight Loss, Side Effects, Cost7 minSemaglutide vs tirzepatide compared: SURMOUNT-5 head-to-head weight loss, SURPASS-2 A1C results, side effect rates from the labels, doses and self-pay cost.
- Ozempic Coupon 2026: $25 Savings Card and $199 Self-Pay7 minOzempic coupon guide for 2026: who gets the $25 savings card, the $100 monthly cap, $199 to $499 self-pay prices, Medicare rules, and how to sign up.
- Retatrutide Price 2026: Why There Is No Real Price Yet6 minRetatrutide price explained: Lilly has set no price, FDA filing is planned for Q1 2027, and online per-month prices are for illegal vials. Real price clues.
- Mounjaro Pill: Is There a Tirzepatide Pill? (2026)7 minIs there a Mounjaro pill? No tirzepatide pill exists. Here is Lilly's GLP-1 pill Foundayo, how it compares to Mounjaro shots, cost, and side effects.
- Peptides FDA Update: HHS Lets Pharmacies Compound 6 Peptides7 minPeptides FDA update, Oct 2026: HHS will not act against pharmacies compounding BPC-157, TB-500, KPV, MOTS-c, Epitalon and Semax. What changes and what does not.
- Counsel Health GLP-1: $300 a Year Program on LillyDirect6 minCounsel Health GLP-1 program: a $300 a year or $29 a visit doctor service on LillyDirect for Zepbound, Wegovy and Foundayo. Costs, how it works and the catch.
- Zepbound Vials: Cost, Instructions, and Vials vs KwikPen7 minZepbound vials explained: $299 to $449 a month on LillyDirect, 0.5 mL per dose, how to draw and inject per the label, storage, and how vials compare to the KwikPen.
- GLP-1 and Type 1 Diabetes: Can You Use It? (2026 Evidence)7 minGLP-1 and type 1 diabetes: no GLP-1 is FDA-approved for type 1, but the ADA now says some adults with obesity can consider one. What the trials show and the risks.
- Mounjaro Heart Benefits: The New FDA Heart Indication Explained6 minMounjaro heart benefits, explained: the FDA heart indication, what SURPASS-CVOT showed vs Trulicity, heart rate changes, and how it compares to Ozempic.
- NovoCare Pharmacy and BlinkRx: Wegovy and Ozempic Prices6 minNovoCare Pharmacy is now powered by BlinkRx. Self-pay Wegovy and Ozempic prices by dose, the $199 new-patient offer, how ordering works, and who can use it.
- GLP-1 While Breastfeeding: What ACOG's New Guidance Says6 minCan you take a GLP-1 while breastfeeding? ACOG's October 2026 advice, what the Wegovy, Zepbound and Foundayo labels say, and why pills are a different story.
- Retatrutide vs Ozempic: Head-to-Head Trial Results (2026)5 minRetatrutide vs Ozempic in the TRANSCEND-T2D-2 head-to-head trial: 20.9% vs 9.4% weight loss, A1C, side effects, quit rates, safety and when it could reach you.
- Andel Wegovy: The New Direct-to-Employer GLP-1 Option6 minAndel Wegovy explained: Andel now offers the Wegovy pill, pen and Wegovy HD through employers. How the Andel GLP-1 benefit works, costs, and who can use it.
- Semaglutide Dosage Chart: Ozempic, Wegovy and Pills (2026)8 minSemaglutide dosage chart from the FDA labels: Ozempic 0.25 to 2 mg, Wegovy 0.25 to 7.2 mg, and the pills. Pen sizes in mL, why units are risky, missed doses.
- Ozempic Australia: PBS Rules, Cost and Weight Loss (2026)6 minOzempic Australia guide: who gets it on the PBS for $25, why weight loss scripts are private, Wegovy PBS news for November 2026, and how to buy it safely.
- Walgreens GLP-1 Program: Cost, Medicare Bridge, How It Works5 minWalgreens GLP-1 program explained: $49 virtual visits, Wegovy, Zepbound and Foundayo prices, new insurance and Medicare GLP-1 Bridge help, and who qualifies.
- Ozempic Price Cut 2027: New $675 List Price, Who Saves6 minOzempic price cut: Novo Nordisk drops the Ozempic, Wegovy and Rybelsus list price to $675 a month on Jan 1, 2027. Who saves, who does not, and Medicare.
- Mounjaro KwikPen India Quality Alert: 6 Batches, What to Do6 minMounjaro KwikPen India alert: six batches, one per strength, were flagged not of standard quality in CDSCO's September 2026 list. Batch numbers and what to do.
- Zepbound Psoriasis: What the Taltz + Zepbound Trials Show7 minZepbound psoriasis guide: in a JAMA Dermatology trial, Taltz plus Zepbound cleared skin fully in 40.6% vs 29.0% on Taltz alone. Results, safety, cost.
- Wegovy Ireland: Price, HSE Funding News and Who Qualifies7 minWegovy Ireland guide for 2026: what it costs per month, why the HSE and medical card do not cover it yet, the new NCPE funding advice and what to do now.
- GLP-1 Pills Over the Counter: Are There Any That Work?6 minAre there GLP-1 pills over the counter? No. Every real GLP-1 pill needs a prescription. What the store "GLP-1" pills are, what OTC options exist and real costs.
- Petrelintide: Roche and Zealand's Weekly Amylin Shot7 minPetrelintide is Zealand Pharma and Roche's weekly amylin shot for weight loss. Phase 2 results, side effects, phase 3 trials and how it compares to GLP-1s.
- LillyDirect Zepbound: Self-Pay Prices, Pharmacy, How It Works6 minLillyDirect Zepbound explained: self-pay prices from $299 a month, the 45-day refill rule, vials vs KwikPen, the four partner pharmacies and how to order.
- HRT and GLP-1: Can You Take Them Together?6 minHRT and GLP-1 drugs can be taken together. New Mayo Clinic data on weight loss, the oral progestogen warning, and what to ask about patches vs pills.
- Ozempic Pill: Doses, Cost, Side Effects and vs Rybelsus7 minThe Ozempic pill is daily oral semaglutide for type 2 diabetes: 1.5, 4 and 9 mg tablets. Label dosing, cost from $149, side effects and how it differs from Rybelsus.
- Is Retatrutide Legal? US, UK, Canada, Australia (2026)7 minIs retatrutide legal? No. It is not approved anywhere, the FDA has warned sellers, and a CBS test of a bodega vial found no drug and 13 bacteria colonies.
- FEHB GLP-1 Coverage 2027: The New Therapy Rule6 minFEHB GLP-1 coverage changes in 2027: Wegovy and Zepbound need a documented behavioral therapy program first. What OPM requires and what to check in Open Season.
- Efpeglenatide (Eppe): Hanmi's Weekly GLP-1, Explained7 minEfpeglenatide, sold as Eppe in Korea, is Hanmi's new weekly GLP-1 shot for weight loss. Approval, trial results, side effects, price and FDA status.
- GLP-1 Pill vs Shot: Which Works Better for Weight Loss?8 minGLP-1 pill vs shot: weight loss results, side effects, daily rules and cost for the Wegovy pill, Foundayo, the Wegovy shot and Zepbound, side by side.
- Retatrutide Sleep Apnea Results: What the NEJM Trials Show7 minRetatrutide sleep apnea results from two phase 3 trials, now in NEJM: how much AHI dropped, how it compares with Zepbound, side effects and FDA timing.
- Mounjaro NHS Criteria 2026: Who Qualifies and When7 minMounjaro NHS criteria for 2026: the BMI and health conditions you need, the cohort dates, how to ask your GP, and what the MPs' rollout report means.
- Chinese GLP-1 Ingredients: FDA Import Alert and Mold Findings6 minChinese GLP-1 ingredient plants: FDA found black mold and hidden records at two semaglutide and tirzepatide suppliers. What the import alerts mean for you.
- Insurance Dropping GLP-1 Coverage in 2027? What to Do Now8 minInsurance dropping GLP-1 coverage for 2027? Why employers are cutting Wegovy and Zepbound, what to check at open enrollment, and your cheapest next options.
- Wegovy Pill Dosage Chart: 1.5 mg to 25 mg, Day by Day7 minWegovy pill dosage chart from the FDA label: 1.5 mg for 30 days, then 4 mg, 9 mg and 25 mg daily. How to take it, missed doses, and pill vs injection doses.
- Generic Semaglutide: Where It Is Sold and When the US Gets It7 minGeneric semaglutide is sold in Canada and India, but not yet in the US. Who makes it, what it costs, how it compares to Ozempic, and the US timeline.
- Zepbound Appeal Letter: Template, Checklist and Deadlines8 minZepbound appeal letter guide: what your doctor's letter of medical necessity needs, a patient letter template, sleep apnea appeals and every deadline.
- Semaglutide Recall 2026: Canada Generics, Compounded Vials, Wegovy7 minSemaglutide recall 2026: Health Canada pulled Apotex and Dr. Reddy's generic pens, the FDA lists compounded vial recalls, and two Wegovy lots. What to check.
- Mounjaro Dosage Chart: Every Dose, Schedule and Pen (2026)6 minMounjaro dosage chart from the FDA label: 2.5 mg start, 2.5 mg steps every 4 weeks, 15 mg max, mL per pen and KwikPen, missed doses and Zepbound doses.
- Medicaid GLP-1 Coverage 2026: Which States Still Pay7 minMedicaid GLP-1 coverage in 2026: what every state must cover, which states dropped weight-loss coverage, the BALANCE model, Indiana, and your options.
- TrumpRx GLP-1 Prices: Wegovy, Ozempic, Zepbound (2026)6 minTrumpRx GLP-1 prices checked Oct 2026: Wegovy pill $149, Wegovy pen and Ozempic $199 to start, Zepbound $299. How it works, who qualifies, and the catches.
- Tirzepatide Recall 2026: Which Vials, and What to Do6 minTirzepatide recall, October 2026: compounded vials from Apothecary Pharma, Houston RX and Carolina Infusion pulled for sterility. Zepbound and Mounjaro are not.
- CagriSema: Women's Results, FDA Date, Side Effects6 minCagriSema (cagrilintide and semaglutide): new REDEFINE 1 data shows 25% average weight loss in women. FDA status, side effects and how it compares to Zepbound.
- Medicare GLP-1 Bridge: Eligibility, $50 Copay, How to Apply7 minMedicare GLP-1 Bridge explained: who qualifies by BMI, the $50 copay for Wegovy, Zepbound and Foundayo, the prior authorization form, and what open enrollment means.
- Amycretin (Zenagamtide): Results, Phase 3, Pill vs Shot7 minAmycretin, now called zenagamtide, is Novo Nordisk's GLP-1 and amylin drug in one molecule. Trial results, AMAZE phase 3, side effects and when it may arrive.
- Retatrutide Clinical Trials: Results, Status, How to Join7 minRetatrutide clinical trials explained: every phase 3 TRIUMPH and TRANSCEND study, results so far, which trials are still enrolling, and how to sign up.
- Mounjaro and Birth Control: Does It Make the Pill Less Effective?6 minMounjaro and birth control: the label says tirzepatide can make the pill less effective. When to add backup, which methods are safe, and Zepbound too.
- Zepbound for Sleep Apnea: Approval, AHI Results, Coverage7 minZepbound sleep apnea guide: what the FDA approved, how much AHI dropped in SURMOUNT-OSA, insurance and Medicare criteria, and whether you still need CPAP.
- Orforglipron for Type 2 Diabetes: Foundayo Results, FDA Status7 minOrforglipron for type 2 diabetes: Foundayo A1C and weight results from the ACHIEVE trials, the heart safety data, and where the FDA review stands now.
- Weight Loss Pill Cost: Every Prescription Pill Priced (2026)7 minWeight loss pill cost in 2026: Wegovy pill and Foundayo from $149 a month, Qsymia $75, Contrave $99. Self-pay, insurance and Medicare prices side by side.
- Foundayo (Orforglipron): Side Effects, Results, and Cost8 minFoundayo (orforglipron) is Lilly's daily GLP-1 pill for weight loss. See the side effects, weight loss results, cost, and how it compares to the Wegovy pill.
- Retatrutide: Side Effects, Results, and FDA Approval Status8 minRetatrutide is Lilly's triple-agonist weight loss shot, still in trials. See the phase 3 results, side effects, FDA timeline, and the black-market risks.
- Wegovy Pill Cost: Self-Pay, Subscription, Insurance, Medicare8 minWegovy pill cost in 2026: $149 to $299 a month self-pay, $249 on a 12-month subscription, $25 with insurance, $50 on Medicare. See every price by dose.
- GLP-1 vs. Peptides: What Is the Difference, and Which Ones Work for Weight Loss?4 minEvery GLP-1 shot is a peptide, but not every peptide is a GLP-1. Here is a plain-English map of approved weight-loss peptides, the ones in trials, and the "research peptides" to avoid.
- Your First 30 Days on GLP-1: A Day-by-Day Survival Guide5 minThe first month on Ozempic, Wegovy, Mounjaro, or Zepbound is the hardest. Here is the day-by-day playbook for managing side effects, hitting protein, and starting strong.
- 15 Questions to Ask Your Doctor When Starting a GLP-15 minMost GLP-1 prescribing visits are 15 minutes long. Here is the printable list of questions that gets you the dose, monitoring, and plan you actually need.
- GLP-1 Medication Comparison: Ozempic vs Wegovy vs Mounjaro vs Zepbound4 minA side-by-side comparison of the major GLP-1 medications: molecule, dosing, cost, FDA indication, side effects, and average weight loss. Pick the right one for your situation.
- Microdosing GLP-1: The Trend, the Reality, and What the Data Shows3 minSome patients use sub-therapeutic GLP-1 doses for "metabolic optimization" or maintenance. Here is what microdosing actually means, who it might help, and what to be skeptical of.
- Rybelsus: The Oral Semaglutide Pill — How It Compares to Injectable3 minRybelsus is oral semaglutide — the same molecule as Ozempic and Wegovy in pill form. Less effective than injectable, but easier to take. Here is what to know.
- GLP-1 Cost and Insurance Coverage: How to Actually Get These Drugs Covered5 minOut-of-pocket costs for GLP-1 medications can run $1,000+ per month. Here is the playbook for insurance coverage, manufacturer programs, and managing prior authorizations.
- GLP-1 Medications and Type 2 Diabetes: How They Lower Blood Sugar3 minGLP-1 drugs were designed to lower blood sugar before they became weight-loss famous. Here's how they work in diabetes, what to expect for HbA1c, and what changes when you also lose weight.
- Compounded GLP-1: What It Is, Why It Exists, and Whether to Trust It3 minCompounded semaglutide and tirzepatide became widely available during shortages. The FDA has tightened rules. Here's how compounding works, the risks, and what to look for.
- Saxenda (Liraglutide): The Daily-Injection GLP-1 That Started It All3 minSaxenda was the first GLP-1 approved for weight loss. It is daily, less effective than semaglutide and tirzepatide, but still has a role for some patients. Here's what you need to know.
- Zepbound vs Mounjaro: When the Same Drug Has Two Brand Names3 minZepbound and Mounjaro are both tirzepatide. The differences are FDA labeling, insurance coverage, and which population they were studied in. Here's the practical breakdown.
- Mounjaro (Tirzepatide): The Dual-Action GLP-1 That Changed the Game3 minMounjaro is tirzepatide — a dual GIP/GLP-1 receptor agonist that consistently outperforms semaglutide in trials. Here's how it works, dosing, side effects, and what to expect.
- Wegovy vs Ozempic: Same Molecule, Different Label — What Actually Differs3 minWegovy and Ozempic are both semaglutide. The differences come down to dose, FDA indication, insurance coverage, and the patient population studied. Here's what you need to know.
- Ozempic for Weight Loss: A Practical Guide for People Who Want to Keep Their Muscle3 minEverything you need to know about Ozempic for weight loss — how semaglutide works, realistic timelines, side effects, dosing, and how to avoid losing muscle while you lose fat.
Lose fat. Not muscle.
One protein number, one 20-minute workout, one score. Every day.